Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFrontier Ip Regulatory News (FIPP)

Share Price Information for Frontier Ip (FIPP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 41.50
Bid: 40.00
Ask: 43.00
Change: 0.00 (0.00%)
Spread: 3.00 (7.50%)
Open: 41.50
High: 41.50
Low: 41.50
Prev. Close: 41.50
FIPP Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Portfolio Company Fundraising - PulsiV Solar Ltd

27 Oct 2015 07:00

RNS Number : 4849D
Frontier IP Group plc
27 October 2015
 

 

 

AIM: FIPP

27 October 2015

 

Frontier IP Group Plc

("Frontier IP" or the "Group")

 

Uplift in Frontier IP's portfolio valuation following completion of PulsiV fundraising

 

 

Frontier IP, which specialises in the commercialisation of intellectual property, is pleased to announce a significant uplift in the value of its portfolio company PulsiV Solar Ltd ("PulsiV Solar"), following the successful completion of PulsiV Solar's first fundraising.

 

PulsiV Solar has received commitments totalling £0.5 million which will result in Frontier IP's holding in PulsiV Solar being revalued to show an uplift of over £0.87 million. The increase will be partially recognised in Frontier IP's financial statements for the year ended 30 June 2015, with the balance expected to be recognised in the Group's interim statements for the six months ending 31 December 2015. The fundraise values PulsiV Solar at £5 million with Frontier IP retaining an 18.9% holding in the issued share capital.

 

PulsiV Solar, which spun-out from Plymouth University, has developed new technology which significantly improves the energy efficiency of photovoltaic solar panels. It does this by maximising the energy generated by the system's inverters, which convert the energy harvested for supply to the grid. The global solar inverter market is forecast to be valued at approximately $7 billion in 2015, according to GTM Research. Results from PulsiV Solar's first prototype show a typical increase of up to 30% in energy generation when compared with conventional inverter technology. The technology can be integrated into new systems or retrofitted to existing solar panels.

 

This fundraising will allow PulsiV Solar to accelerate product development, enabling further prototyping and testing in preparation for the initial production of micro-inverters containing its technologies.

 

Dr. Mohamed Zaki Ahmed, Chief Technology Officer of PulsiV Solar, said:

 

"Frontier IP has played a key role in enabling us to successfully close our first fundraising. Frontier is also leveraging its relationships in the energy sector to open up further opportunities as we look to realise the commercial potential of PulsiV Solar's technology. We are delighted to have Frontier IP's active involvement in the commercialisation process and look forward to the next stage in our growth."

 

Neil Crabb, Chief Executive of Frontier IP, said:

 

"The technology being developed by our portfolio company PulsiV Solar, has the potential to drive significant gains in the energy efficiency of solar panels and other photovoltaic systems. We have been delighted to assist with the Company's first funding round and will continue to deploy our energy sector experience to take this ground-breaking technology to market."

 

Enquiries

 

Frontier IP Group Plc

T: 0131 240 1251

Neil Crabb, Chief Executive

Company website: www.frontierip.co.uk

 

Cantor Fitzgerald Europe

(Nominated Adviser and Joint Broker)

T: 020 7894 7000

David Foreman, Catherine Leftley, Corporate Finance

David Banks, Corporate Broking

Peterhouse Corporate Finance Limited

(Joint Broker)

T: 020 7469 0935

Lucy Williams

Kreab

T: 020 7074 1800

Robert Speed, Matthew Jervois

 

 

Notes to Editor:

 

About Frontier IP Group plc

www.frontierip.co.uk.

 

Frontier IP specialises in assisting institutions and companies in the commercialisation and exploitation of their intellectual property. It establishes formal and informal relationships with sources of exploitable IP, principally universities. Its core business is building and growing a portfolio of equity stakes in spin-out companies by taking an active involvement in the commercialisation and funding of these businesses. Frontier IP currently has seventeen companies in its portfolio, which exploit IP from a range of institutions.

About PulsiV Solar Limited

 

PulsiV Solar was set up by Dr. Mohamed Zaki Ahmed, Plymouth University and Frontier IP Group PLC and develops a novel inverter technology to improve power take-off from photovoltaic solar panels. PulsiV Solar's technology aims to maximise the energy generated by solar inverters and is a potentially disruptive technology, capable of retro-fit. The PulsiV Solar team is based at Plymouth University, with key strategic and support functions being provided by Frontier IP Group plc.

Dr Mohammed Zaki Ahmed, Chief Technology Officer of PulsiV Solar, has led the development of this breakthrough technology and has a successful track record with other innovations, including train collision avoidance systems, which are now widely adopted across the world.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCDQLFLEBFXFBQ
Date   Source Headline
2nd Dec 20227:00 amRNSThe Vaccine Group completes vaccine project
30th Nov 20225:00 pmRNSTotal Voting Rights
25th Nov 20222:23 pmRNSDirector/PDMR Shareholding
23rd Nov 20225:17 pmRNSDirector share transfers
18th Nov 20223:53 pmRNSExercise of Options & PDMR Shareholdings
11th Nov 20223:07 pmRNSDirector/PDMR Dealing
11th Nov 20227:00 amRNSPosting of Annual Report and Notice of AGM
8th Nov 20227:00 amRNSPulsiv announces £1.5m fundraise
1st Nov 20221:46 pmEQSFrontier IP Group 'rigged for a storm' but confident of more progress
27th Oct 20227:00 amRNSFinal Results
19th Oct 20224:22 pmRNSHolding(s) in Company
19th Oct 20223:29 pmRNSHolding(s) in Company
14th Oct 20227:00 amRNSElute Intelligence appoints Steve Cable as CEO
27th Sep 20227:00 amRNSPulsiv unveils power electronics technology
18th Aug 20223:20 pmRNSSale of shares in Exscientia
5th Aug 20227:00 amRNSCamGraPhIC announces £1.26 million fundraising
26th Jul 20224:26 pmRNSHolding(s) in Company
26th Jul 20224:07 pmRNSHolding(s) in Company
24th May 20227:00 amRNSCambridge Raman Imaging raises £1.1 million
19th May 20227:00 amRNSPublication of newsletter
12th Apr 20225:18 pmRNSHolding(s) in Company
17th Mar 20227:00 amRNSUnaudited Half Year Results
14th Feb 20227:00 amRNSSale of shares in Exscientia
11th Feb 20225:04 pmRNSHolding(s) in Company
11th Feb 20222:05 pmRNSHolding(s) in Company
10th Feb 20227:00 amRNSCambridge Raman Imaging wins European Union grant
25th Jan 20227:00 amRNSSale of shares in Exscientia
17th Jan 20225:56 pmRNSHolding(s) in Company
12th Jan 20227:00 amRNSTrading update
11th Jan 20227:00 amRNSCelerum launch first commercial product
9th Dec 20212:33 pmRNSResult of AGM
29th Nov 20217:00 amRNSTVG - milestone in development of COVID-19 vaccine
9th Nov 20217:00 amRNSPosting of Annual Accounts and Notice of AGM
28th Oct 20217:00 amRNSDirectorate Change
28th Oct 20217:00 amRNSFinal Results
15th Oct 20217:00 amRNSPublication of newsletter
1st Oct 20217:59 amRNSPricing of IPO of Exscientia in the United States
30th Sep 20217:00 amRNSCamGraPhIC raises £1.6 million
27th Sep 20213:56 pmRNSUpdate on proposed IPO of Exscientia
24th Sep 20217:00 amRNSHolding(s) in Company
13th Sep 20217:00 amRNSExscientia - Statement filed for proposed IPO
8th Sep 20211:24 pmRNSExscientia enters $70M collaboration
8th Jul 20217:00 amRNSCamGraPhIC loan facility of up to £1.5 million
15th Jun 20217:00 amRNSPulsiv appoints Adam Westcott as CFO
14th Jun 20217:00 amRNSNandi Proteins appoints David Flower as CEO
11th Jun 20217:00 amRNSPublication of newsletter
24th May 20217:00 amRNSPulsiv complete £1.5m fundraising and appoints CEO
19th May 202111:53 amRNSExscientia collaboration with Bristol Myers Squibb
6th May 20217:00 amRNSThe Vaccine Group appoints Jeremy Salt as CEO
30th Apr 20211:58 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.